AR042000A1 - Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados - Google Patents
Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializadosInfo
- Publication number
- AR042000A1 AR042000A1 ARP030104096A ARP030104096A AR042000A1 AR 042000 A1 AR042000 A1 AR 042000A1 AR P030104096 A ARP030104096 A AR P030104096A AR P030104096 A ARP030104096 A AR P030104096A AR 042000 A1 AR042000 A1 AR 042000A1
- Authority
- AR
- Argentina
- Prior art keywords
- patients
- fosinopril
- dialized
- cardiovascular events
- reduce cardiovascular
- Prior art date
Links
- BIDNLKIUORFRQP-XYGFDPSESA-N (2s,4s)-4-cyclohexyl-1-[2-[[(1s)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([P@@](=O)(O[C@H](OC(=O)CC)C(C)C)CC(=O)N1[C@@H](C[C@H](C1)C1CCCCC1)C(O)=O)CCCC1=CC=CC=C1 BIDNLKIUORFRQP-XYGFDPSESA-N 0.000 title abstract 2
- 229960002490 fosinopril Drugs 0.000 title abstract 2
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 230000007211 cardiovascular event Effects 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 abstract 1
- 238000001631 haemodialysis Methods 0.000 abstract 1
- 230000000322 hemodialysis Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Abstract
Uso de fosinopril o una de sus sales farmacéuticamente aceptables, para reducir el riesgo de ocurrencia de un evento cardiovascular en pacientes dializados, en donde el evento cardiovascular es una insuficiencia cardíaca, en particular en pacientes hemodializados, especialmente pacientes que presentan una hipertrofia ventricular izquierda.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0214060A FR2846886A1 (fr) | 2002-11-08 | 2002-11-08 | Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR042000A1 true AR042000A1 (es) | 2005-06-08 |
Family
ID=32116508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030104096A AR042000A1 (es) | 2002-11-08 | 2003-11-07 | Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060135482A1 (es) |
| EP (1) | EP1558267A1 (es) |
| JP (1) | JP2006506405A (es) |
| KR (1) | KR20050072480A (es) |
| CN (1) | CN1708308A (es) |
| AR (1) | AR042000A1 (es) |
| AU (1) | AU2003278059A1 (es) |
| BR (1) | BR0316059A (es) |
| CA (1) | CA2505324A1 (es) |
| FR (1) | FR2846886A1 (es) |
| MX (1) | MXPA05004753A (es) |
| PL (1) | PL374906A1 (es) |
| WO (1) | WO2004041290A1 (es) |
| ZA (1) | ZA200504652B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006100602A2 (en) * | 2005-03-22 | 2006-09-28 | Aurobindo Pharma Ltd | Immediate release stable solid oral dosage forms op fosinopril |
| ES2489741T3 (es) * | 2005-07-08 | 2014-09-02 | Mochida Pharmaceutical Co., Ltd. | Composición para la prevención de la aparición de acontecimientos cardiovasculares |
| US20070087975A1 (en) * | 2005-10-17 | 2007-04-19 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| SI23149A (sl) * | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4931464A (en) * | 1989-02-15 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
| US20030040509A1 (en) * | 2001-08-06 | 2003-02-27 | Genomed, Llc | Methods and compositions for treating diseases associated with excesses in ACE |
| BR0308053A (pt) * | 2002-02-28 | 2004-12-28 | Novartis Ag | Stents revestidos com n-{5-[4-(4-metil-piperazino-metil)-benzoilamido]-2-metil fenil}-4-(3-piridil)-2-pirimidina-amina |
-
2002
- 2002-11-08 FR FR0214060A patent/FR2846886A1/fr active Pending
-
2003
- 2003-10-09 BR BR0316059-9A patent/BR0316059A/pt not_active Application Discontinuation
- 2003-10-09 KR KR1020057008049A patent/KR20050072480A/ko not_active Withdrawn
- 2003-10-09 US US10/534,052 patent/US20060135482A1/en not_active Abandoned
- 2003-10-09 PL PL03374906A patent/PL374906A1/xx unknown
- 2003-10-09 WO PCT/EP2003/011147 patent/WO2004041290A1/en not_active Ceased
- 2003-10-09 EP EP03769362A patent/EP1558267A1/en not_active Withdrawn
- 2003-10-09 CN CNA2003801019861A patent/CN1708308A/zh active Pending
- 2003-10-09 AU AU2003278059A patent/AU2003278059A1/en not_active Abandoned
- 2003-10-09 CA CA002505324A patent/CA2505324A1/en not_active Abandoned
- 2003-10-09 MX MXPA05004753A patent/MXPA05004753A/es not_active Application Discontinuation
- 2003-10-09 JP JP2004548734A patent/JP2006506405A/ja active Pending
- 2003-11-07 AR ARP030104096A patent/AR042000A1/es unknown
-
2006
- 2006-01-11 ZA ZA200504652A patent/ZA200504652B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0316059A (pt) | 2005-09-27 |
| CN1708308A (zh) | 2005-12-14 |
| ZA200504652B (en) | 2006-03-29 |
| WO2004041290A1 (en) | 2004-05-21 |
| PL374906A1 (en) | 2005-11-14 |
| CA2505324A1 (en) | 2004-05-21 |
| JP2006506405A (ja) | 2006-02-23 |
| US20060135482A1 (en) | 2006-06-22 |
| EP1558267A1 (en) | 2005-08-03 |
| MXPA05004753A (es) | 2005-08-02 |
| AU2003278059A1 (en) | 2004-06-07 |
| FR2846886A1 (fr) | 2004-05-14 |
| KR20050072480A (ko) | 2005-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR087241A2 (es) | Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica | |
| NO20074824L (no) | Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter | |
| BRPI0416628A (pt) | uso de compostos orgánicos | |
| NO20044436L (no) | Substituerte fenyleddiksyrer | |
| AR018717A1 (es) | COMPUESTOS DERIVADOS DE PIPERIDINA, SU USO, UN PROCESO PARA SU PREPARACIoN, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, Y COMPUESTOS INTERMEDIARIOS. | |
| MXPA03006855A (es) | Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion. | |
| BR0209948A (pt) | Inibidores de fator inibitório de migração de macrófago e métodos para identificar os mesmos | |
| NO20060416L (no) | Ny anvendelse I | |
| BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
| BRPI0413695A (pt) | derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas | |
| UY27518A1 (es) | Nuevos derivados de pirrolidina | |
| BR0307590A (pt) | Laminado | |
| NO20060847L (no) | Substituert 2-aminotetralin til behandling av depresjon | |
| NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| HN2004000109A (es) | Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso | |
| AR039633A2 (es) | Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica | |
| HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
| PA8548501A1 (es) | Nuevos derivados de acido sulfonico | |
| AR111374A1 (es) | Uso de lik066 en pacientes con insuficiencia cardíaca | |
| SE0201940D0 (sv) | New combination II | |
| CO6531499A2 (es) | Uso de ranolazina para el tratameinto de enfermedades cardiovasculares | |
| AR042000A1 (es) | Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados | |
| CR9073A (es) | Coadministracion de tigeciclina y digoxin | |
| SE0200198D0 (sv) | New use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |